Dermatology / Collaborating with the life-sciences industry
These articles fall under two themes. The first is Dermatology and the second is ‘collaborating with the life-sciences industry’.
The three articles that have been published look at how researchers are taking a fresh look at medicines and using innovative devices and treatment methods in an attempt to improve quality of life for patients.
We shine a light on how the NIHR Clinical Research Network (CRN) is supporting a new study that could revolutionise treatment for diabetic-related sight impairment, and save the NHS money.
Vitiligo is a condition in which areas of skin lose their normal pigment and so become white. Although not life-threatening, it can have a profound impact on the quality of life of the people it affects. Currently there are three recommended treatments options and little evidence to say which works best. New thinking suggests a combination a treatments could lead to better outcomes. We take a look at HI-Light Vitiligo, a study exploring if this is the case or not.
As any parent or children’s health professional will attest, the flavour of medicine can be a cause of great anxiety. It can affect children’s relationship with healthcare and undermine the effectiveness of treatments. The fundamental question remains: why aren’t children’s medicines more palatable? One of the reasons is that there is no scale to measure whether a medicine tastes OK to children, or not. And that’s where the ACCEPT clinical research study comes in…